Clinical trial Recruiting at 1 site Interventional Ages 60 to 75

Individualized exercise program for elderly patients with coronary heart disease

Official title: Effect of Individualized Exercise Based on CPET on Multiple Cardiovascular Risk Factors and Cardiopulmonary Function in Elderly Patients With Coronary Heart Disease

Run by The First Affiliated Hospital with Nanjing Medical University · NCT06588231 · Data updated 2026-11-12

This study tests whether a personalized exercise program can help older patients with coronary heart disease feel better physically and mentally.

Quick facts

Study typeInterventional
Ages60 Years to 75 Years
SexAll
Enrollment200 (estimated)
SponsorThe First Affiliated Hospital with Nanjing Medical University
Academic / other
Locations1 site (Nanjing, Jiangsu)
StatusRecruiting
StartedOctober 17, 2023
Main results expectedDecember 17, 2024
Study endsAugust 17, 2025
Registry record updatedDecember 31, 2024
Trial IDNCT06588231 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are elderly individuals aged 60-75 with stable coronary heart disease confirmed by angiography and a left ventricular ejection fraction greater than 40%.

Probably not a fit

Patients with severe comorbidities, uncontrolled hypertension, or significant physical limitations may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on the effects of a personalized exercise rehabilitation program for elderly patients diagnosed with coronary heart disease. It aims to improve patients' physical and mental health through tailored exercise prescriptions based on individual evaluations. The program includes comprehensive interventions such as optimal medical therapy alongside exercise training to enhance overall quality of life and prognosis. The study is grounded in evidence-based practices recommended by major cardiovascular health organizations.

Why it matters

Potential benefit: If successful, this approach could significantly enhance the quality of life and health outcomes for elderly patients with coronary heart disease.

How similar studies have gone: Previous studies have shown positive outcomes with similar individualized exercise rehabilitation approaches in cardiac patients, supporting the potential effectiveness of this intervention.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Coronary heart disease: coronary angiography confirmed patients with coronary heart disease.
* Age is 60-75 years old, and the clinical sinus rhythm is stable.
* Left ventricular ejection fraction was\> 40%.
* Informed consent and voluntary participation.

Exclusion Criteria:

* Patients with severe organic cardiac and lung diseases.
* Patients with hemiplegia and other physical action disorders.
* A history of mental illness.
* Uncontrolled hypertension, and hemodynamic instability.
* Severe nephropathy and severe peripheral artery disease.
* Patients with bone and joint diseases who are not suitable for exercise.
* Uncontrolled endocrine system and other diseases.
* Antibiotics and anti-diarrheal medications have not been used for at least 3 months.

Where it's running

  • the First Affiliated Hospital of Nanjing Medical University
    Nanjing, Jiangsu, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.